Premiers rsultats cliniques : Dans deux petites tudes cliniques, les agonistes du GLP-1 ont rduit la consommation dalcool et lenvie de boire chez des patients souffrant de troubles lis la consommation dalcool et ont rduit de 40 % lenvie de boire des opiodes chez des patients souffrant de troubles lis la consommation dopiodes (5)
I try very hard, even in these times, to understand what people are going through when they're angry or hateful or when they're doing things that just don't feel right
The American Diabetes Association and American Heart Association recommend GLP-1 agonists for weight management in eligible patients
Biological Activity KLOW exerts its biological effects through coordinated action across cellular repair, inflammation regulation, and oxidative protection pathways
Prioritize Balanced Meals Many people taking GLP-1 medications unintentionally eat too little because their appetite is greatly reduced
John Roxborough, MD , offers GLP-1 weight loss services that provide a scientifically proven path to sustainable, long-term results